Bluebird hopes for 3 drug approvals by 2019, including CAR-T and gene therapies – Endpoints News
Endpoints News |
Bluebird hopes for 3 drug approvals by 2019, including CAR-T and gene therapies
Endpoints News The FDA already gave the program breakthrough therapy designation. The CAR-T was the star of ASH when blurbird reported extremely high response and remission rates with good safety in a small study. Leschly said Celgene will file for US and European … |
